Country: United States
Language: English
Source: NLM (National Library of Medicine)
SULFANILAMIDE (UNII: 21240MF57M) (SULFANILAMIDE - UNII:21240MF57M)
Meda Pharmaceuticals
SULFANILAMIDE
SULFANILAMIDE 15 g in 100 g
VAGINAL
PRESCRIPTION DRUG
For the treatment of vulvovaginitis caused by Candida albicans . (See CLINICAL PHARMACOLOGY.) AVC should not be used in patients known to be sensitive to this product or to the sulfonamides. Tolerance, abuse, or dependence with AVC have not been reported.
AVC Cream NDC 0037-6631-04 4 oz tube with applicator Store at room temperature, below 86°F. Protect from cold. Product darkens with age. Potency is maintained throughout labeled shelf life when stored as directed. This leaflet provides a summary of the important information about AVC Cream. You can get more information by calling the toll free number (1-877-999-8403). Distributed by: Meda Pharmaceuticals Somerset, New Jersey 08873-4120 ©2018 Mylan Specialty L.P. AVC is a registered trademark of Meda Pharma S.A.R.L., a Mylan company. 141016 IN-663103-02 Rev. 6/2018
New Drug Application
AVC- SULFANILAMIDE CREAM MEDA PHARMACEUTICALS ---------- AVC CREAM (SULFANILAMIDE) 15% AVC (sulfanilamide) Cream DESCRIPTION AVC is a preparation for vaginal administration for the treatment of _Candida albicans_ infections and available in the following form: AVC Cream Each tube contains: Sulfanilamide.............................................................................................15.0% in a water-miscible, non-staining base made from lactose, propylene glycol, stearic acid, diglycol stearate, methylparaben, propylparaben, trolamine, and water; buffered with lactic acid to an acid pH of approximately 4.3. Sulfanilamide is an anti-infective agent. It is p-amino-benzenesulfonamide with the chemical structure: Sulfanilamide occurs as a white odorless crystalline powder with a slightly bitter taste and sweet aftertaste. It is slightly soluble in water, alcohol, acetone, glycerin, propylene glycol, hydrochloric acid, and solutions of potassium and sodium hydroxide. It is practically insoluble in chloroform, ether, benzene, and petroleum ether. CLINICAL PHARMACOLOGY Sulfanilamide has been a useful ingredient of vaginal formulations for about four decades. It blocks certain metabolic processes essential for the growth of susceptible bacteria. In AVC, the sulfanilamide is in a specially compounded base buffered to the pH (about 4.3) of the normal vagina to encourage the presence of the normally occurring Döderlein’s bacilli of the vagina. The use of AVC for the treatment of vulvovaginitis caused by _Candida albicans_ is supported by three clinical investigations. The three studies show AVC with sulfanilamide to be significantly more effective (p ≤ 0.01) than placebo as follows: In Study I, the ratio of effectiveness was 71% for the AVC with sulfanilamide versus 49% for placebo with 30 days of treatment; In Study II, the percentages were 48% and 24%, respectively, with 15 days of treatment; In Study III, the percentages were 66% versus 33%, respectively, with 30 days of treatment. INDICATIONS AND USAGE F Read the complete document